You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Details for Patent: 6,977,077


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,977,077
Title: Method of increasing bone toughness and stiffness and reducing fractures
Abstract:The invention relates to a method for increasing the toughness and/or stiffness of bone and/or reducing the likelihood and/or severity of bone fracture by administering a parathyroid hormone. The method can be employed to increase toughness or stiffness of bone at a site of a potential or actual trauma, such as the hip or spine of a person at risk of or suffering from osteoporosis. The method of the invention can reduce the incidence of vertebral fracure, reduce the incidence of multiple vertebral fractures, reduce the severity of vertebral fracture, and/or reduce the incidence of non-vertebral fracture.
Inventor(s): Hock; Janet M. (Indianapolis, IN), Gaich; Gregory A. (Indianapolis, IN), Dere; Willard H. (Westlake Village Ventura, CA)
Assignee: Eli Lilly and Company (Indianapolis, IN)
Application Number:09/647,278
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 6,977,077
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,977,077

Introduction to Patent 6,977,077

United States Patent 6,977,077, hereafter referred to as the '077 patent, is a specific patent that has been granted by the U.S. Patent and Trademark Office (USPTO). To analyze this patent, we need to delve into its claims, scope, and the broader patent landscape.

What is a Patent?

A patent is a form of intellectual property that gives the patent holder the exclusive right to make, use, and sell an invention for a certain period of time, usually 20 years from the date of filing. In the United States, patents are governed by the USPTO and are subject to various laws and regulations, including those outlined in 35 U.S.C. § 101[1].

Determining the Scope of a Patent

The scope of a patent is primarily defined by its claims. The claims section of a patent is the most critical part, as it delineates what the inventor considers to be the invention and what is protected by the patent.

Claim Language and Metrics

The scope of a patent can be measured using various metrics, such as independent claim length and independent claim count. These metrics are important because they can indicate the breadth and clarity of the patent. For instance, narrower claims are often associated with a higher probability of grant and a shorter examination process compared to broader claims[3].

Analyzing the Claims of Patent 6,977,077

To analyze the '077 patent, one must carefully review its claims. Here are some key steps:

Independent Claims

  • Independent claims are the broadest claims in a patent and define the invention without reference to other claims. They are crucial in determining the scope of the patent.
  • For the '077 patent, identifying the independent claims will help in understanding the core aspects of the invention.

Dependent Claims

  • Dependent claims are narrower and refer back to one or more of the independent claims. They add additional limitations to the independent claims and can help in defining the invention more precisely.
  • Analyzing dependent claims can provide insights into the specific features and embodiments of the invention.

Claim Construction

  • Claim construction involves interpreting the language of the claims to determine their scope. This process is critical in patent litigation and can significantly impact the enforceability of the patent.
  • The USPTO and courts use various tests, such as the "plain and ordinary meaning" rule, to interpret claim language[1].

Patent Subject Matter Eligibility

Patent subject matter eligibility is a critical aspect of patent law, governed by 35 U.S.C. § 101. This section outlines four statutory categories for patentable subject matter: processes, machines, manufactures, and compositions of matter. However, not all subject matter within these categories is eligible for a patent.

The Alice Test

  • The Alice test, established by the Supreme Court in the case of Alice Corp. v. CLS Bank International, is used to determine the eligibility of software and business method patents.
  • The test involves two steps: first, determining whether the claim is directed to an abstract idea, natural phenomenon, or law of nature; and second, evaluating whether the claim adds an "inventive concept" to the abstract idea[1].

Inventorship and Ownership

Proper inventorship is essential for the validity and enforceability of a patent. In the United States, the true and only inventors must be listed on the patent application.

Determining True Inventors

  • The process of invention involves conception of the idea and reduction to practice. Only those who contribute to these steps should be listed as inventors[2].
  • Errors in inventorship can be corrected, but deceptive intent can render the patent unenforceable.

Patent Landscape and Global Dossier

Understanding the broader patent landscape is crucial for assessing the significance and potential impact of the '077 patent.

Global Dossier

  • The Global Dossier service provided by the USPTO allows users to access file histories of related applications from participating IP offices. This can help in identifying patent families and understanding the global context of the '077 patent[4].

Public Search Facilities

  • The USPTO Public Search Facility and other resources like the Main STIC Library offer access to patent and trademark information, which can be used to conduct thorough searches and analyses of related patents[4].

Statistical Analysis and Metrics

To further analyze the '077 patent, statistical metrics such as patent maintenance payments, forward citations, and the breadth of patent classes can be used.

Forward Citations

  • Forward citations indicate how often a patent is cited by later patents. A high number of forward citations can suggest that the '077 patent is influential in its field.

Patent Maintenance Payments

  • Patent maintenance payments are fees paid to keep the patent in force. Analyzing these payments can provide insights into the economic value and longevity of the patent[3].

Key Takeaways

  • Claims Analysis: The scope of the '077 patent is defined by its claims, with independent claims being the broadest and most critical.
  • Subject Matter Eligibility: The patent must pass the Alice test to ensure it is eligible for protection under 35 U.S.C. § 101.
  • Inventorship: Proper determination of true inventors is crucial for the validity and enforceability of the patent.
  • Global Context: Using tools like Global Dossier can help in understanding the global patent landscape and the '077 patent's place within it.
  • Statistical Metrics: Metrics such as forward citations and patent maintenance payments can provide additional insights into the patent's impact and value.

FAQs

Q: What is the significance of independent claims in a patent? A: Independent claims are the broadest claims in a patent and define the invention without reference to other claims, thereby determining the scope of the patent.

Q: How does the Alice test impact software and business method patents? A: The Alice test determines whether a claim is directed to an abstract idea and whether it adds an "inventive concept," which is crucial for the eligibility of software and business method patents.

Q: Why is proper inventorship important in patent applications? A: Proper inventorship is essential because errors or deceptive intent in naming inventors can render the patent invalid or unenforceable.

Q: What is the Global Dossier service provided by the USPTO? A: The Global Dossier service allows users to access file histories of related applications from participating IP offices, helping to identify patent families and understand the global context.

Q: How can statistical metrics like forward citations and patent maintenance payments be useful? A: These metrics can indicate the influence and economic value of the patent, providing insights into its impact and longevity.

Sources

  1. BitLaw: Patent Law in the United States - BitLaw
  2. Oregon State University: Determining Inventorship for US Patent Applications
  3. SSRN: Patent Claims and Patent Scope
  4. USPTO: Search for patents - USPTO

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 6,977,077

ApplicantTradenameGeneric NameDosageNDAApproval DateTETypeRLDRSPatent No.Patent ExpirationProductSubstanceDelist Req.Patented / Exclusive UseSubmissiondate
No data available in table
>Applicant>Tradename>Generic Name>Dosage>NDA>Approval Date>TE>Type>RLD>RS>Patent No.>Patent Expiration>Product>Substance>Delist Req.>Patented / Exclusive Use>Submissiondate
Showing 0 to 0 of 0 entries

Foreign Priority and PCT Information for Patent: 6,977,077

PCT Information
PCT FiledAugust 19, 1999PCT Application Number:PCT/US99/18961
PCT Publication Date:March 02, 2000PCT Publication Number: WO00/10596

International Family Members for US Patent 6,977,077

CountryPatent NumberEstimated ExpirationSupplementary Protection CertificateSPC CountrySPC Expiration
Argentina 033639 ⤷  Try for Free
Australia 5575099 ⤷  Try for Free
Australia 746277 ⤷  Try for Free
Austria 231000 ⤷  Try for Free
>Country>Patent Number>Estimated Expiration>Supplementary Protection Certificate>SPC Country>SPC Expiration
Showing 1 to 4 of 4 entries

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.